z-logo
open-access-imgOpen Access
Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients
Author(s) -
Vimal K. Derebail,
Patrick H. Nachman,
Nigel S. Key,
Heather Ansede,
Ronald J. Falk,
Wayne D. Rosamond,
Abhijit V. Kshirsagar
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/vbge-xq73
Subject(s) - erythropoiesis , dosing , hemodialysis , phenotype , hemoglobin , medicine , differential (mechanical device) , erythropoietin , anemia , biology , genetics , gene , engineering , aerospace engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom